Conopco, Inc.

Form 483 issued April 6, 2022 · Jefferson City, Missouri

Inspection
Mar 29 – Apr 6, 2022
Investigator
Jill Tillman
Observations
3
Pages
3
FEI number
1947127

In short: On April 6, 2022, FDA issued a Form 483 with 3 observations to Conopco, Inc. in Jefferson City, Missouri (FEI 1947127) after an inspection that ran Mar 29 – Apr 6, 2022. The investigator was Jill Tillman. Most observations concern laboratory controls and materials.

At a glance

2 of 3 observations on this 483 concern laboratory controls.

Laboratory controls2
Materials1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Each lot of components and drug product containers is not withheld from use until the lot…

  2. 02

    Laboratory controls do not include the establishment of scientifically sound and appropriate sampling plans and test…

  3. 03

    Reserve samples from representative sample lots or batches of drug products selected by acceptable statistical procedures…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Conopco, Inc.?

FDA listed 3 observations on this Form 483, mostly about laboratory controls and materials. The opening words of each observation are shown on this page.

Who inspected Conopco, Inc.?

Jill Tillman is named on this Form 483, for the inspection of Mar 29 – Apr 6, 2022. Each investigator has a profile showing what they cite most.

When was Conopco, Inc. inspected by FDA?

The inspection ran Mar 29 – Apr 6, 2022, and the Form 483 is dated April 6, 2022.

How do I get the full Form 483 for Conopco, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free